Literature DB >> 26916174

Should we treat obesity in COPD? The effects of diet and resistance exercise training.

Vanessa M McDonald1,2,3,4, Peter G Gibson2,3,4, Hayley A Scott5,3, Penelope J Baines1,3, Michael J Hensley2,3,4, Jeffrey J Pretto3,4, Lisa G Wood5,3.   

Abstract

BACKGROUND AND
OBJECTIVE: Obesity is an established risk factor for poor health outcomes, but paradoxically in chronic obstructive pulmonary disease (COPD), it is associated with improved survival and lung function. A major evidence gap exisits to inform treatment recommendations for patients with COPD who are obese. We aimed to determine the effect of weight reduction involving a low-energy diet utilizing a partial meal replacement plan, coupled with resistance exercise training in obese COPD patients.
METHODS: In a proof of concept before-after clinical trial, obese (body mass index ≥30 kg/m(2) ) COPD patients received a 12 week weight reduction programme involving meal replacements, dietary counselling by a dietitian and resistance exercise training prescribed and supervised by a physiotherapist. Patients were reviewed face to face by the dietitian and physiotherapist every 2 weeks for counselling.
RESULTS: Twenty-eight participants completed the intervention. Mean (standard deviation) body mass index was 36.3 kg/m(2) (4.6) at baseline and reduced by 2.4 kg/m(2) ((1.1) P < 0.0001) after the intervention. Importantly, skeletal muscle mass was maintained. Clinical outcomes improved with weight loss including exercise capacity, health status, dyspnea, strength and functional outcomes. There was also a significant reduction in the body mass index, obstruction, dyspnea and exercise score (BODE). Systemic inflammation measured by C-reactive protein however did not change.
CONCLUSION: In obese COPD patients, dietary energy restriction coupled with resistance exercise training results in clinically significant improvements in body mass index, exercise tolerance and health status, whilst preserving skeletal muscle mass. This novel study provides a framework for development of guidelines for the management of obese COPD patients and in guiding future research.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  COPD; muscle mass; obesity; weight loss

Mesh:

Year:  2016        PMID: 26916174     DOI: 10.1111/resp.12746

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  21 in total

1.  Validation of Predictive Metabolic Syndrome Biomarkers of World Trade Center Lung Injury: A 16-Year Longitudinal Study.

Authors:  Sophia Kwon; George Crowley; Erin J Caraher; Syed Hissam Haider; Rachel Lam; Arul Veerappan; Lei Yang; Mengling Liu; Rachel Zeig-Owens; Theresa M Schwartz; David J Prezant; Anna Nolan
Journal:  Chest       Date:  2019-03-02       Impact factor: 9.410

2.  Treating Severe Obesity to Reduce Dyspnea in Patients With Chronic Lung Disease: A Pilot Mixed Methods Study.

Authors:  Kara L Dupuy-McCauley; Paul J Novotny; Roberto P Benzo
Journal:  Chest       Date:  2020-03-04       Impact factor: 9.410

Review 3.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

4.  Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.

Authors:  Syed H Haider; Assad Oskuei; George Crowley; Sophia Kwon; Rachel Lam; Jessica Riggs; Mena Mikhail; Angela Talusan; Arul Veerappan; James S Kim; Erin J Caraher; Anna Nolan
Journal:  Eur Respir Rev       Date:  2019-03-27

Review 5.  Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience.

Authors:  Kenneth A Wilson; Manish Chamoli; Tyler A Hilsabeck; Manish Pandey; Sakshi Bansal; Geetanjali Chawla; Pankaj Kapahi
Journal:  Cell Metab       Date:  2021-09-22       Impact factor: 31.373

6.  Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.

Authors:  Peter A Jacobsen; Alex J van 't Hul; Remco S Djamin; Jeanine C Antons; Marianne de Man; Ulla Møller Weinreich; Martijn A Spruit; Daisy J A Janssen
Journal:  Respir Res       Date:  2021-05-12

Review 7.  COPD and exercise: does it make a difference?

Authors:  Martijn A Spruit; Chris Burtin; Patrick De Boever; Daniël Langer; Ioannis Vogiatzis; Emiel F M Wouters; Frits M E Franssen
Journal:  Breathe (Sheff)       Date:  2016-06

8.  Feasibility, tolerance and effects of adding impact loading exercise to pulmonary rehabilitation in people with chronic obstructive pulmonary disease: study protocol for a pilot randomised controlled trial.

Authors:  Erin Cecins; Kylie Hill; Dennis R Taaffe; David Manners; Anne-Marie Hill; Robert U Newton; Daniel A Galvão; Vinicius Cavalheri
Journal:  Pilot Feasibility Stud       Date:  2021-08-03

9.  Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.

Authors:  Netsanet A Negewo; Vanessa M McDonald; Katherine J Baines; Peter Ab Wark; Jodie L Simpson; Paul W Jones; Peter G Gibson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-01

10.  Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.

Authors:  Netsanet A Negewo; Peter G Gibson; Peter Ab Wark; Jodie L Simpson; Vanessa M McDonald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.